✨ Health and Housing Notices




NEW ZEALAND GAZETTE, No. 97 β€” 27 OCTOBER 2016

Notice of Registration of Community Housing Provider

Pursuant to section 166(3) of the Housing Restructuring and Tenancy Matters Act 1992, this is notice of the registration of Porirua Whanau Centre Trust as a community housing provider.

Full name of community housing provider: Porirua Whanau Centre Trust
Address: 16 Bedford Court
Porirua 5024
Registration No.: RA051
Class of registration: Class 1 - Social Landlord
Approval No.: 040
Date of approval of registration: 21 October 2016

COMMUNITY HOUSING REGULATORY AUTHORITY.


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: 4% Articadent DENTAL with Adrenaline 1:100,000
Active Ingredients: Adrenaline acid tartrate 10mcg/mL
Articaine hydrochloride 40mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Dentsply (NZ) Limited
Manufacturer: Laboratorios INIBSA, Barcelona, Spain

Product: Solifenacin
Active Ingredient: Solifenacin succinate 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: PSM Healthcare Limited trading as API Consumer Brands
Manufacturer: Jubilant Generics Limited, Bhagwanpur, India

Product: Solifenacin
Active Ingredient: Solifenacin succinate 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: PSM Healthcare Limited trading as API Consumer Brands
Manufacturer: Jubilant Generics Limited, Bhagwanpur, India

Dated this 21st day of October 2016.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).


Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: PipTaz BNM
Active Ingredients: Piperacillin monohydrate 4000mg
Tazobactam 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited trading as BNM Group
Manufacturer: Mitim SrL, Brescia, Italy

Dated this 21st day of October 2016.



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 97





✨ LLM interpretation of page content

Notice of Registration of Community Housing Provider

Housing & Social Welfare
21 October 2016
Community Housing, Registration, Porirua Whanau Centre Trust, Social Landlord
  • COMMUNITY HOUSING REGULATORY AUTHORITY

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
21 October 2016
Medicine Consent, Articadent DENTAL, Solifenacin, Adrenaline, Distribution
  • DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
21 October 2016
Medicine Consent, PipTaz BNM, Piperacillin, Tazobactam, Distribution
  • DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health